Deal Announcements

Anexon Reports $7 Million Venture Capital Investment

Thursday, October 21, 2010 5:34:00 AM PDT | VentureDeal Staff

Cambridge, Massachusetts  --  Biotechnology company Anexon (no website) has secured $7 million in additional investment according to SEC regulatory filings.

Anexon is a very early stage company that is developing therapeutics for cardiovascular disease.

Investors in the round were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1